Prediction of overall survival or progression free survival by disease control rate at week 8 is independent of ethnicity: Western versus Chinese patients with first-line non-small cell lung cancer treated with chemotherapy with or without bevacizumab
Claret, Laurent, Gupta, Manish, Han, Kelong, Joshi, Amita, Sarapa, Nenad, He, Jing, Powell, Bob, Bruno, RenéVolume:
54
Language:
english
Journal:
The Journal of Clinical Pharmacology
DOI:
10.1002/jcph.191
Date:
March, 2014
File:
PDF, 323 KB
english, 2014